Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
Adriana Amaro(Ospedale Policlinico San Martino), Michela Croce(Ospedale Policlinico San Martino)
Cited by 26
Related Papers
The biology of uveal melanoma
|Cancer and Metastasis Reviews|2017|243